Stand Up To Cancer

COVID-19 Resources for Cancer Patients and Caregivers

Visit our resource page with information from trusted sources and SU2C-affiliated institutions.

LEARN MORE

Latest Updates

Stand Up To Cancer Hails FDA Approval of Olaparib for Advanced Prostate Cancer

A recent FDA approval supported by Stand Up To Cancer...

New Therapy for Advanced BRAF-mutated Colorectal Cancer

SU2C is excited to announce the 7th FDA-approved treatment...

A Message from SU2C CEO, Sung Poblete

The coronavirus pandemic is disrupting our home and work...

COVID Symptom Study App

This morning we are proud to announce an initiative that...

Stand Up for All of Us

Cancer clinical trials may be the right option for you...

CANCER KNOWS NO LIMITS

Stand Up To Cancer (SU2C) funds and develops the newest and most promising cancer treatments to help patients today. SU2C dramatically accelerates the rate of new discoveries by connecting top scientists in unprecedented collaborations to create breakthroughs. SU2C innovations lead to better cancer prevention, diagnosis, and treatment, which means that we can help save lives now.

Today alone, 4,949 people in the United States will be diagnosed with cancer. Progress against one type of cancer is progress against ALL cancer. That’s why we’re committed to funding the most promising and ambitious research.
When you support Stand Up To Cancer, you’re supporting research to find the newest and best treatments for all cancer patients.

100% of donations received from the public support
Stand Up To Cancer’s collaborative cancer research programs.

WHAT WE DO

OUR UNIQUE APPROACH

Historically, scientists have worked independently on different pieces of the cancer puzzle or have studied the same cancer questions without coordinating their efforts or sharing data. SU2C funds multidisciplinary, multi-institutional, collaborative research projects that address critical problems in cancer prevention, diagnosis, and treatment to deliver near-term patient benefit. This innovative approach is transforming cutting-edge cancer research.

Collaboration

SU2C’s unique funding model mandates collaboration and innovation among our researchers and includes over 1,600 scientists across more than 180 institutions.

Acceleration

SU2C funds scientifically rigorous, patient-focused research to accelerate the development of new treatments for people with cancer. The SU2C research portfolio includes 108 collaborative research teams, as well as 49 individual early-career investigators to bring new scientists and their ideas into cancer research.

Breakthrough Research

By innovating new ways for researchers to work together and providing substantial funding to deliver results, SU2C makes breakthroughs happen.
SU2C-supported research has already lead to 8 new FDA-approved cancer treatments.

WHO WE ARE

SU2C accelerates groundbreaking cancer research that delivers the latest therapies to patients to help save lives now.

LEARN MORE

WHAT WE DO

SU2C funds collaboration among the best and brightest researchers to accelerate the rate of new discoveries in cancer prevention, diagnosis, and treatment. We create awareness and build broad public support for this effort.

LEARN MORE

TAKE ACTION

SU2C is dedicated to forming a unified front against cancer through fundraising, community engagement, and education. Join us today and make an impact.

LEARN MORE

Clinical trials work to get effective treatments from the lab to patients. Learn more about clinical trials, and see if one may be right for you or someone you love.

CLINICAL TRIALS